Neurodevelopmental outcomes at five years after early-onset fetal growth restriction: Analyses in a Dutch subgroup participating in a European management trial.


Journal

European journal of obstetrics, gynecology, and reproductive biology
ISSN: 1872-7654
Titre abrégé: Eur J Obstet Gynecol Reprod Biol
Pays: Ireland
ID NLM: 0375672

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 20 09 2018
revised: 23 11 2018
accepted: 28 12 2018
pubmed: 21 1 2019
medline: 31 5 2019
entrez: 21 1 2019
Statut: ppublish

Résumé

The objective of this study is to explore developmental outcomes at five years after early-onset fetal growth restriction (FGR). Retrospective data analysis of prospective follow-up of patients of three Dutch centres, who participated in a twenty centre European randomized controlled trial on timing of delivery in early-onset FGR. Developmental outcome of very preterm infants born after extreme FGR is assessed at (corrected) age of five. Seventy-four very preterm FGR children underwent follow-up at the age of five. Mean gestational age at birth was 30 weeks and birth weight was 910 g, 7% had a Bayley score <85 at two years. Median five years' FSIQ was 97, 16% had a FSIQ < 85, and 35% had one or more IQ scores <85. Motor score ≤ 7 on movement ABC-II (M-ABC-II-NL) was seen in 38%. Absent or reversed end-diastolic flow, gestational age at delivery, birthweight and neonatal morbidity were related to an FSIQ < 85. Any abnormal IQ scale score was related to birthweight, male sex and severity of FGR, and abnormal motor score to male sex and bronchopulmonary dysplasia (BPD). Overall, median cognitive outcome at five years was within normal range, but 35% of the children had any abnormal IQ score at age five, depending on the IQ measure, and motor impairment was seen in 38% of the children. GA at delivery, birthweight, EDF prior to delivery and neonatal morbidity were the most important risk factors for cognitive outcomes.

Identifiants

pubmed: 30660941
pii: S0301-2115(19)30031-4
doi: 10.1016/j.ejogrb.2018.12.041
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

63-70

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

A Pels (A)

Department of Obstetrics and Gynecology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: a.pels@amc.uva.nl.

O C Knaven (OC)

Department of Obstetrics and Gynecology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.

B J Wijnberg-Williams (BJ)

Department of Pediatrics, Isala Hospital, Zwolle, the Netherlands.

M J C Eijsermans (MJC)

Child Development & Exercise Center, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, the Netherlands.

S M Mulder-de Tollenaer (SM)

Department of Pediatrics, Isala Hospital, Zwolle, the Netherlands.

C S H Aarnoudse-Moens (CSH)

Department of Pediatrics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.

C Koopman-Esseboom (C)

Child Development & Exercise Center, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, the Netherlands.

J van Eyck (J)

Department of Obstetrics and Gynecology, Isala Hospital, Zwolle, the Netherlands.

J B Derks (JB)

Department of Obstetrics, Gynecology and Neonatology, Wilhelmina Children's Hospital University Medical Center, Utrecht, the Netherlands.

W Ganzevoort (W)

Department of Obstetrics and Gynecology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.

A G van Wassenaer-Leemhuis (AG)

Department of Pediatrics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH